Bad Blood

In this gripping national bestseller, prize-winning journalist John Carreyrou investigates the rise and fall of Elizabeth Holmes and her startup, Theranos, which promised revolutionary blood-testing technology. Initially celebrated as a tech visionary, Holmes attracted significant investment, valuing the company at over $9 billion, only for the world to discover that the groundbreaking device was fundamentally flawed. As patients faced serious risks from erroneous test results, Carreyrou unveils a chilling narrative of ambition gone awry, corporate deception, and the lengths to which Holmes and her partner went to silence dissenting voices.